Featured in NEJM Journal Watch: Spironolactone Mitigates Rosacea Risk (FREE)
By the NEJM Journal Watch Editors
In a large population-based analysis, spironolactone users …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news